Reverse the expression levels of TNF-α, IL-6, IL-1β, and NF-κB in liver tissues of NAFLD rats and decrease the expression of inflammatory chemokines CCL2 and CXCL10. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.